Hormone replacement therapy and cardiovascular disease the current status of research and practice
This is a high-level, clinical reference by world-class specialists on the efficacy of hormone replacement therapy for the primary prevention of cardiovascular risk in postmenopausal women. Specific chapters cover pulsed estrogen therapy with Aerodiol and cardiovascular risk assessment in postmenopa...
Saved in:
Other Authors: | |
---|---|
Format: | Book |
Language: | English |
Published: |
New York
Parthenon Publ-Group
2001
|
Series: | Controversial issues in climacteric medicine series
|
Subjects: | |
Online Access: | Click Here to View Status and Holdings. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000nam a2200000#i 4501 | ||
---|---|---|---|
001 | wils-282826 | ||
005 | 202443112756 | ||
008 | 240503t2001 NYU a# #001 deng D | ||
020 | # | # | |a 9781842140383 |q hardback |
020 | # | # | |a 1842140388 |q hardback |
040 | # | # | |a DNLM |d UiTM |e rda |
041 | 0 | # | |a English |
060 | 0 | 0 | |a WG 166 |
090 | 0 | 0 | |a WG166 |b C764 2001 |
245 | 0 | 0 | |a Hormone replacement therapy and cardiovascular disease |b the current status of research and practice |c edited by A.R. Genazzani |
264 | # | 1 | |a New York |b Parthenon Publ-Group |c 2001 |
264 | # | 4 | |c ©2001 |
300 | # | # | |a viii, 188 pages |b illustrations |c 25 cm |
336 | # | # | |a text |b txt |2 rdacontent |
337 | # | # | |a unmediated |b n |2 rdamedia |
338 | # | # | |a volume |b nc |2 rdacarrier |
490 | 1 | # | |a Controversial issues in climacteric medicine series |
500 | # | # | |a "Published under the auspices of the International Menopause Society." |
504 | # | # | |a Includes bibliographical references and index. |
520 | # | # | |a This is a high-level, clinical reference by world-class specialists on the efficacy of hormone replacement therapy for the primary prevention of cardiovascular risk in postmenopausal women. Specific chapters cover pulsed estrogen therapy with Aerodiol and cardiovascular risk assessment in postmenopausal hormone replacement therapies such as Livial (tibolone). This volume is based on the formal presentations and subsequent discussions that took place at the International Menopause Society specially convened Expert Workshop on Hormone Replacement Therapy and Cardiovascular Disease, London, UK, October 13-16, 2000 |
650 | 1 | 2 | |a Cardiovascular Diseases |c Congress |x drug therapy |
650 | 1 | 2 | |a Cardiovascular Diseases |v Congress |x prevention & control |
650 | 2 | 2 | |a Cardiovascular System |v Congress |x drug effects |
650 | 2 | 2 | |a Hormone Replacement Therapy |v Congress |x methods |
650 | 2 | 2 | |a Postmenopause |v Congress |x drug effects |
650 | 2 | 2 | |a Women's Health |v Congress |
700 | 1 | # | |a Genazzani, A.R. |e editor |
856 | 4 | 0 | |z Click Here to View Status and Holdings. |u https://opac.uitm.edu.my/opac/detailsPage/detailsHome.jsp?tid=282826 |
964 | # | # | |c BOK |d MD |
998 | # | # | |a 00264#1a006.2.2||00264#1b006.2.2||00300##a006.2.2||00300##b006.2.2||00300##c006.2.2||00500##a006.2.2||00520##a006.2.2||00520##b006.2.2|| |